NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced it has resubmitted its ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, responds to the public disclosure of ...

–TrenibotE is a first-in-class botulinum neurotoxin serotype E characterized by a rapid onset of action as early as 8 hours after administration (earliest assessment time) and shorter duration of ...

Move over, Botox — there’s a new skin-jectable on the block, and it lasts even longer. Seriously. Enter: Daxxify, otherwise known as Daxi, and short for the more formal term, DaxibotulinumtoxinA-lanm.

The US Food and Drug Administration (FDA) has approved daxibotulinumtoxinA-lanm injection (Daxxify) for the temporary improvement in the appearance of moderate to severe glabellar lines (frown lines) ...

Botox, or botulinum toxin, might be most popularly known as a treatment for wrinkles; it's a neurotoxic agent produced by Clostridium botulinum bacteria, and works by causing a mild, local paralysis.

Sept 7 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Revance Therapeutics' (RVNC.O), opens new tab anti-wrinkle injection, setting up a challenger for market leader AbbVie's ...

There's been a great deal of hue and cry over the proposed "Botax" that's been running through Congress. That's the street name for a suggested 5% levy on elective cosmetic surgery procedures that ...